21.53
+0.96(+4.67%)
Currency In USD
| Previous Close | 20.57 |
| Open | 20.63 |
| Day High | 21.55 |
| Day Low | 20.4 |
| 52-Week High | 21.56 |
| 52-Week Low | 8.03 |
| Volume | 1.91M |
| Average Volume | 1.78M |
| Market Cap | 2.58B |
| PE | -29.49 |
| EPS | -0.73 |
| Moving Average 50 Days | 16.64 |
| Moving Average 200 Days | 14.77 |
| Change | 0.96 |
If you invested $1000 in Arcutis Biotherapeutics, Inc. (ARQT) since IPO date, it would be worth $987.61 as of October 08, 2025 at a share price of $21.53. Whereas If you bought $1000 worth of Arcutis Biotherapeutics, Inc. (ARQT) shares 3 years ago, it would be worth $1,130.78 as of October 08, 2025 at a share price of $21.53.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5
GlobeNewswire Inc.
Oct 06, 2025 12:00 PM GMT
ZORYVE cream 0.05% provides rapid and effective relief of mild to moderate atopic dermatitis in children ages 2 to 5 and is safe and well toleratedOnce-daily, steroid-free cream can be used anywhere on the body for any durationAbout 1.8 million child
Arcutis Biotherapeutics to Host Virtual Investor Day and Report Third Quarter 2025 Financial Results on October 28, 2025
GlobeNewswire Inc.
Sep 29, 2025 8:00 PM GMT
WESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on immuno-dermatology, today announced that it will report third quarter 2025 financial
Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress
GlobeNewswire Inc.
Sep 17, 2025 8:00 AM GMT
New analysis of ZORYVE foam 0.3% demonstrates reduction in signs and symptoms of seborrheic dermatitis in individuals with diverse skin typesNew data show improved quality of life and decreased impact on families for investigational ZORYVE cream 0.05